Medical Resources restructures board
Gordon Strickland has been named chairman of imaging services provider Medical Resources, the Hackensack, NJ, company reported this month. Strickland replaces Gary Siegler, who was at the center of a controversy over acquisition advisory fees that
Gordon Strickland has been named chairman of imaging services provider Medical Resources, the Hackensack, NJ, company reported this month. Strickland replaces Gary Siegler, who was at the center of a controversy over acquisition advisory fees that derailed the company's consolidation effort last year.
Strickland has been a member of the company's board since December. Although Siegler is stepping down from his position as chairman, he remains on the company's board and still owns about 18% of the firm. In conjunction with Strickland's appointment, Medical Resources added two new members to its board, Sally Crawford and Peter Davis.
In other Medical Resources news, the company reported financial results for the first quarter (end-March) that included a sharp increase in revenue but also a higher net loss due to one-time charges and litigation costs. For the quarter, Medical Resources posted revenue of $67.1 million, up 68% compared with $40 million in revenues in the first quarter of 1997.
Medical Resources recorded a net loss for the quarter of $4.9 million, compared with net income of $3.6 million in the same period the year before. Of the loss, $3.8 million was due to unusual charges. Medical Resources president and CEO Duane Montopoli said that, despite the increased loss, the company believes that its business is beginning to show improvement.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
